Beyond the Pill — Pharma Takes a Stake In Digital Health
Rhenu Bhuller, a founding member of Frost & Sullivan’s Asia Pacific operations and expert in analysing the…
As the most important pharma hub in its region, and one of the most important globally, many companies look to launch new products in Singapore first before expanding to other…
Rhenu Bhuller, a founding member of Frost & Sullivan’s Asia Pacific operations and expert in analysing the…
The ongoing COVID-19 pandemic is a double-edged sword for Singapore. While its economy has been hit by the global…
Ai Hua Ong, Company Group Chairman, Asia Pacific, The Janssen Pharmaceutical Companies of Johnson & Johnson.…
In an exclusive and wide-ranging interview, Harjit Gill outlines the work of pan-Asia-Pacific medtech association APACMed, how COVID-19 represents a chance to change the global narrative on medtech in healthcare, and the key trends shaping the region’s dynamic market. We often use the term “learning and leapfrogging” in Asia-Pacific, meaning that necessity has become a mother to innovation. For…
Singapore is home to a wide range of biopharmaceutical company headquarters, many of them regional bases, and…
The ongoing COVID-19 pandemic is a double-edged sword for Singapore. While its economy has been hit by the global…
A brief overview of the situation regarding biosimilars & biologics in Singaporean Pharma. Prepared in…
Since gaining independence in 1965, Singapore has invested heavily in moving beyond being a mere supplier of low…
Singapore’s location at the heart of the APAC region, expertise in logistics and cold chain management, and…
Singapore, though conscious of its limitations, has been able to leverage its key assets of location,…